EDITORIAL

BioBoard

JAPAN
•  Study notes widening disease transmission by monkeys

MALAYSIA
•  Drug-resistant malaria threatens control programs

SINGAPORE
•  Novel gene predicts both breast cancer relapse and response to chemotherapy
•  New drug formulations to boost fight against respiratory illnesses and antibiotic-resistant superbugs
•  Zebrafish genes linked to human respiratory diseases
•  Singapore researchers discover a gene that increases incidence of acute myelogenous leukemia
•  Scientists develop green tea-based 'missiles' to kill cancer cells more effectively

UNITED STATES
•  Large study reveals new genetic variants that raise risk for prostate cancer
•  Math model designed to replace invasive kidney biopsy for lupus patients
•  Mayo Clinic researchers reveal pathway that contributes to Alzheimer’s disease
•  Immunotherapy combination demonstrates superior anti-cancer activity

EYE ON CHINA
•  Milestone Scientific and Milestone China form new dermatological joint venture
•  BGI and The Vancouver Prostate Centre to create joint research laboratory for advancement of translational cancer research
•  BGI Tech, DLF-Trifolium A/S, and Aarhus University applying genomic selection methods to enhance forage grass varieties
•  Ioxus to be incorporated in China as Ioxus (Shanghai) Clean Energy Technology
•  Tsinghua and UC Berkeley launch research and graduate education partnership
•  Altor BioScience and Shenzhen Beike Biotechnology enter license agreement for immunotherapeutic ALT-803 in China
•  3SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China

FEATURES
•  Site Mapping the Innovative Way
•  The Art of Site Selection – How Sites Without Trials Experience Could Help Bolster Study Performance
•  Become Greats through GREATS
•  Unraveling Heart Failure: Looking at an Asian Phenotype
•  Recognizing Opportunities Amidst Biopharma Challenges in China

PEOPLE WATCH
•  Tackling Resistance with RNA

INSIDE INDUSTRY
•  Innovation in Academic Medicine
•  Merck Serono awards Grant for Growth Innovation (GGI) for the first time
•  National Cancer Institute awards KIYATEC nearly $2M to fund 3D breast cancer, 3D brain cancer micro-tumor development
•  Frost & Sullivan honors 2014 Growth, Innovation & Leadership Award winners
•  Abcam licenses novel Ceefourin inhibitors of multidrug resistance protein 4 from Australia’s Children’s Cancer Institute
•  Daiichi Sankyo further expands TaNeDS collaborative drug discovery program in Europe
•  Veolia Water Technologies South-East Asia to provide advanced water solutions for Tun Razak Exchange Project in Malaysia
•  Biocept and Rosetta Genomics collaborate to evaluate microRNAs from circulating tumor cells
•  Biocept expands collaboration with MD Anderson Cancer Center

•  CONFERENCE CALENDAR